Best Practice & Research Clinical Rheumatology
Volume 22, Issue 5 , Pages 831-845, October 2008

The antiphospholipid syndrome

Clinical Immunology Department, Nouvel Hopital Civil, Hopitaux Universitaires de Strasbourg, Université de Strasbourg and INSERM, U737, 67091 Strasbourg, France

The antiphospholipid syndrome is an acquired autoimmune syndrome characterized by arterial and/or venous thrombosis and/or pregnancy morbidity in association with the prolonged presence of serum autoantibodies, including the so-called lupus anticoagulant and anticardiolipin antibodies, which are mainly directed against complexes of proteins and anionic phospholipids.

Key words: anticardiolipin antibodies, antiphospholipid syndrome, lupus anticoagulant

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6942(08)00097-1

doi:10.1016/j.berh.2008.08.008

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 5 , Pages 831-845, October 2008